Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia
A Multi-center Randomized Clinical Trial of Regulating Gut Microbiota by Probiotic Agents in Management of Immune Thrombocytopenia
Sponsor: Jinan Central Hospital
A PHASE2 clinical study on Immune Thrombocytopenia, this trial is ongoing. The trial is conducted by Jinan Central Hospital and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2
-
Feb 2019 — Jan 2021 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE2
▶ Show 1 earlier version
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Jinan Central Hospital
- Qianfoshan Hospital
- Qingdao University
- Shandong University
- The Second Hospital of Shandong University
- Yantai Yuhuangding Hospital
For direct contact, visit the study record on ClinicalTrials.gov .